Legal & General Group Plc Increases Stake in Thermo Fisher Scientific Inc (NYSE:TMO)

Legal & General Group Plc boosted its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 3.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,864,050 shares of the medical research company’s stock after buying an additional 69,279 shares during the period. Legal & General Group Plc owned approximately 0.48% of Thermo Fisher Scientific worth $286,323,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Wellington Management Group LLP boosted its stake in Thermo Fisher Scientific by 5.6% in the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock worth $1,153,867,000 after buying an additional 398,622 shares during the period. Pictet Asset Management Ltd. boosted its position in shares of Thermo Fisher Scientific by 1.2% in the first quarter. Pictet Asset Management Ltd. now owns 2,407,464 shares of the medical research company’s stock worth $369,786,000 after buying an additional 29,513 shares in the last quarter. Pioneer Investment Management Inc. boosted its position in shares of Thermo Fisher Scientific by 1.6% in the first quarter. Pioneer Investment Management Inc. now owns 2,219,085 shares of the medical research company’s stock worth $340,851,000 after buying an additional 34,012 shares in the last quarter. Findlay Park Partners LLP boosted its position in shares of Thermo Fisher Scientific by 20.8% in the first quarter. Findlay Park Partners LLP now owns 2,032,151 shares of the medical research company’s stock worth $312,138,000 after buying an additional 350,000 shares in the last quarter. Finally, C WorldWide Group Holding A S boosted its position in shares of Thermo Fisher Scientific by 997.1% in the first quarter. C WorldWide Group Holding A S now owns 1,950,049 shares of the medical research company’s stock worth $299,527,000 after buying an additional 1,772,300 shares in the last quarter. Institutional investors own 87.60% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded down 0.19% during trading on Friday, reaching $172.57. 1,182,702 shares of the company traded hands. The stock has a market capitalization of $67.32 billion, a PE ratio of 30.06 and a beta of 1.06. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $182.87. The firm’s 50-day moving average is $176.71 and its 200-day moving average is $166.56.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.03 EPS. On average, equities analysts predict that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be given a $0.15 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.35%. Thermo Fisher Scientific’s dividend payout ratio is presently 10.45%.

COPYRIGHT VIOLATION NOTICE: This report was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.com-unik.info/2017/08/19/legal-general-group-plc-has-286-32-million-position-in-thermo-fisher-scientific-inc-nysetmo-updated-updated.html.

A number of brokerages have commented on TMO. Bank of America Corporation raised their price target on shares of Thermo Fisher Scientific from $190.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, May 9th. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Jefferies Group LLC raised their price target on shares of Thermo Fisher Scientific from $160.00 to $175.00 and gave the company a “hold” rating in a report on Friday, April 28th. BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. Finally, Citigroup Inc. reaffirmed a “buy” rating and issued a $201.00 price objective (up from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. One equities research analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $188.56.

In other news, Director Jim P. Manzi sold 11,318 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the completion of the sale, the director now directly owns 38,757 shares in the company, valued at $6,702,635.58. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Daniel P. Shine sold 4,688 shares of the firm’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $171.88, for a total value of $805,773.44. Following the transaction, the insider now owns 29,200 shares in the company, valued at approximately $5,018,896. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,506 shares of company stock valued at $6,834,758. 0.49% of the stock is owned by corporate insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit